Evidence map›Paper›PMID 39436053›Full record

ArticleInfection and immunity2024

A single immunization of

Gavin Z Chambers, Kathryn M F Chambers, Richard T Marconi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Protective efficacy of mutant strains ofInfection and immunity · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gavin Z ChambersDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
Kathryn M F ChambersDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
Richard T MarconiDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.ORCID 0000-0002-6035-7306

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Chimeric epitope based vaccines for tick borne infectionsR01AI141801 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI MARCONI, RICHARD T · 2019 to 2022
$2.5M
OspC and its role in defining host range and dissemination propertiesR01AI165876 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI MARCONI, RICHARD T · 2022 to 2025
$2.2M
VCU Initiative for Maximizing Student Development Program (IMSD)T32GM148403 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI AKBARALI, HAMID I, ESCALANTE, CARLOS R · 2023 to 2025
$647k
Initiative for Maximizing Student Development D32 GM148403NIAID NIH HHS R01 AI141801NIAID NIH HHS R01 AI165876NIGMS NIH HHS T32 GM148403NIH HHS P51 OD011104
6 · The paper itself

Abstract

Lyme disease, caused by

Indexed as

Antibodies, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsBorrelia burgdorferiLipoproteinsLyme DiseaseAnimalsAntibody FormationAntigens, SurfaceBacterial VaccinesFemaleImmunizationLyme Disease VaccinesMiceMice, Inbred C3HVaccines, SubunitAntibodies, BacterialAntigens, BacterialAntigens, SurfaceBacterial Outer Membrane ProteinsBacterial VaccinesLipoproteinsLyme Disease VaccinesOspA proteinOspC proteinVaccines, SubunitCH14crLymeDCFL4dogsLyme diseaseLyme vaccinesOspAOspC

Identifiers

PMID39436053
PMCPMC11556006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.